PKCα-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-β1

被引:0
作者
Ying Chen
Guanzhen Yu
Danghui Yu
Minghua Zhu
机构
[1] Changhai Hospital,Department of Pathology
[2] Second Military Medical University,Department of Oncology
[3] Changzheng Hospital,undefined
[4] Second Military Medical University,undefined
来源
Journal of Experimental & Clinical Cancer Research | / 29卷
关键词
Pancreatic Cancer; Gemcitabine; Pancreatic Cancer Cell; Pancreatic Cancer Cell Line; BxPC3 Cell;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 122 条
[1]  
Bergman PJ(1997)Potent induction of human colon cancer uptake of chemotherapeutic drugs by N-myristoylated protein kinase C-alpha (PKC-alpha) pseudosubstrate peptides through a P-blycoprotein-independent mechanism Invest New Drugs 15 311-318
[2]  
Gravitt KR(1994)Evidence that protein kinase C-alpha activation is a critical event in phorbol ester-induced multiple drug resistance in human colon cancer cells Biochem Phamacol 48 375-381
[3]  
Ward NE(2006)Inhibitory effect of curcumin on MDR1 gene expression in patient leukemic cells Arch Pharm Res 29 866-873
[4]  
Gravitt KR(2007)Development and validation of a phosphorylated SMAD ex vivo stimulation assay Biomarker 12 313-330
[5]  
Ward NE(2007)Tumor microenvironment: hypoxia and buffer capacity for immunotherapy Med Hypotheses 69 590-595
[6]  
Fan D(2008)The functional implications of Akt activity and TGF-beta signaling in tamoxifen-resistant breast cancer Bichim biophys Acta 1783 438-447
[7]  
Anuchapreeda S(1996)Role of TGF beta in the anti-estrogen response/resistance of human breast cancer J Mammary Gland Biol Neoplasia 1 381-389
[8]  
Thanarattanakom P(2006)Inhibition of TGFbeta signaling in cancer therapy Curr Opin Genet Dev 16 30-37
[9]  
Sittipreechacham S(1991)Response of prostate cancer cells to peptide growth factors: transforming growth factor-beta Cancer Surv 11 147-163
[10]  
Famington DL(2007)Tumor evasion of the immune system by converting CD4+CD25-T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta J Immunol 178 2883-2892